{"title":"Malarial chemoprophylaxis and the healing of periodontal lesions.","authors":"S A Ogunwande","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A randomized study was carried out using 92 patients (39 taking a malarial chemoprophylactic agent and 53 not taking a chemoprophylactic agent) to investigate the rate of healing of ulcerative periodontitis after treatment. The chemoprophylaxis group who had been on 300 mg chloroquine weekly for at least one year and the non-chemoprophylaxis group who had not been on the regimen for at least one year were involved in the study which examined the global efficacy and assessment for pain relief over a period of 12 weeks after treatment for ulcerative periodontitis. A detailed, symtomatic and clinical assessment was made at biweekly intervals. Relief from pain was higher for the non-chemoprophylaxis group (94.2% vs. 46.2%, p less than 0.05). The global efficacy was statistically significant for the non-chemoprophylaxis group (87% vs. 38.4%, p less than 0.05). The outcome of treatment was not influenced by factors such as duration of chemoprophylaxis, initial severity of pain and smoking habits of the patients.</p>","PeriodicalId":75715,"journal":{"name":"Clinical preventive dentistry","volume":"13 2","pages":"5-8"},"PeriodicalIF":0.0000,"publicationDate":"1991-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical preventive dentistry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A randomized study was carried out using 92 patients (39 taking a malarial chemoprophylactic agent and 53 not taking a chemoprophylactic agent) to investigate the rate of healing of ulcerative periodontitis after treatment. The chemoprophylaxis group who had been on 300 mg chloroquine weekly for at least one year and the non-chemoprophylaxis group who had not been on the regimen for at least one year were involved in the study which examined the global efficacy and assessment for pain relief over a period of 12 weeks after treatment for ulcerative periodontitis. A detailed, symtomatic and clinical assessment was made at biweekly intervals. Relief from pain was higher for the non-chemoprophylaxis group (94.2% vs. 46.2%, p less than 0.05). The global efficacy was statistically significant for the non-chemoprophylaxis group (87% vs. 38.4%, p less than 0.05). The outcome of treatment was not influenced by factors such as duration of chemoprophylaxis, initial severity of pain and smoking habits of the patients.
对92例患者(39例使用疟疾化学预防药物,53例未使用化学预防药物)进行随机对照研究,观察溃疡性牙周炎治疗后的治愈率。化学预防组每周服用300mg氯喹至少一年,非化学预防组至少一年没有服用该方案,参与了这项研究,该研究检查了溃疡性牙周炎治疗后12周内疼痛缓解的总体疗效和评估。每两周进行一次详细的症状和临床评估。非化学预防组疼痛缓解率更高(94.2%比46.2%,p < 0.05)。非化学预防组总体疗效有统计学意义(87% vs. 38.4%, p < 0.05)。治疗结果不受化疗预防持续时间、初始疼痛严重程度和患者吸烟习惯等因素的影响。